Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy

RD Sanderson, M Elkin, AC Rapraeger, N Ilan… - The FEBS …, 2017 - Wiley Online Library
Because of its impact on multiple biological pathways, heparanase has emerged as a major
regulator of cancer, inflammation and other disease processes. Heparanase accomplishes …

Algal polysaccharides as therapeutic agents for atherosclerosis

NP Patil, V Le, AD Sligar, L Mei, D Chavarria… - Frontiers in …, 2018 - frontiersin.org
Seaweed-derived polysaccharides including agar and alginate, have found widespread
applications in biomedical research and medical therapeutic applications including wound …

Heparanase: From basic research to therapeutic applications in cancer and inflammation

I Vlodavsky, P Singh, I Boyango, L Gutter-Kapon… - Drug resistance …, 2016 - Elsevier
Heparanase, the sole heparan sulfate degrading endoglycosidase, regulates multiple
biological activities that enhance tumor growth, angiogenesis and metastasis. Heparanase …

Role of heparanase in tumor progression: Molecular aspects and therapeutic options

V Masola, G Zaza, G Gambaro, M Franchi… - Seminars in Cancer …, 2020 - Elsevier
Heparanase (HPSE) is an endoglycosidase that catalyses the cutting of the side chains of
heparan-sulphate proteoglycans (HS), thus determining the remodelling of the extracellular …

Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice

I Lerner, E Hermano, E Zcharia… - The Journal of …, 2011 - Am Soc Clin Investig
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that is closely associated
with colon cancer. Expression of the enzyme heparanase is clearly linked to colon …

Glycosaminoglycans contribute to extracellular matrix fiber recruitment and arterial wall mechanics

JM Mattson, R Turcotte, Y Zhang - Biomechanics and modeling in …, 2017 - Springer
Elastic and collagen fibers are well known to be the major load-bearing extracellular matrix
(ECM) components of the arterial wall. Studies of the structural components and mechanics …

Loss of syndecan-1 induces a pro-inflammatory phenotype in endothelial cells with a dysregulated response to atheroprotective flow

PL Voyvodic, D Min, R Liu, E Williams, V Chitalia… - Journal of Biological …, 2014 - ASBMB
Fluid shear stresses are potent regulators of vascular homeostasis and powerful
determinants of vascular disease progression. The glycocalyx is a layer of …

[HTML][HTML] Versatile role of heparanase in inflammation

R Goldberg, A Meirovitz, N Hirshoren, R Bulvik… - Matrix Biology, 2013 - Elsevier
Heparanase is the only known mammalian endoglycosidase capable of degrading heparan
sulfate glycosaminoglycan, both in extracellular space and within the cells. It is tightly …

Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression

M Blich, A Golan, G Arvatz, A Sebbag… - … , and vascular biology, 2013 - Am Heart Assoc
Objective—Factors and mechanisms that activate macrophages in atherosclerotic plaques
are incompletely understood. We examined the capacity of heparanase to activate …

Heparanase: a novel therapeutic target for the treatment of atherosclerosis

TK Nguyen, S Paone, E Chan, IKH Poon, AA Baxter… - Cells, 2022 - mdpi.com
Cardiovascular disease (CVD) is the leading cause of death and disability worldwide, and
its management places a huge burden on healthcare systems through hospitalisation and …